nodes	percent_of_prediction	percent_of_DWPC	metapath
Misoprostol—Arterial thrombosis—Methotrexate—bone cancer	0.0205	0.0224	CcSEcCtD
Misoprostol—Thromboembolic event—Methotrexate—bone cancer	0.0205	0.0224	CcSEcCtD
Misoprostol—Infection—Carboplatin—bone cancer	0.0122	0.0133	CcSEcCtD
Misoprostol—Loss of libido—Methotrexate—bone cancer	0.012	0.0131	CcSEcCtD
Misoprostol—Rectal disorder—Epirubicin—bone cancer	0.0105	0.0115	CcSEcCtD
Misoprostol—Pain—Carboplatin—bone cancer	0.0105	0.0114	CcSEcCtD
Misoprostol—Anorectal disorder—Epirubicin—bone cancer	0.00982	0.0107	CcSEcCtD
Misoprostol—Rectal disorder—Doxorubicin—bone cancer	0.00975	0.0107	CcSEcCtD
Misoprostol—Body temperature increased—Carboplatin—bone cancer	0.00967	0.0106	CcSEcCtD
Misoprostol—Neuropathy—Cisplatin—bone cancer	0.00944	0.0103	CcSEcCtD
Misoprostol—Anorectal disorder—Doxorubicin—bone cancer	0.00909	0.00994	CcSEcCtD
Misoprostol—Embolism—Methotrexate—bone cancer	0.0086	0.00941	CcSEcCtD
Misoprostol—Phlebitis—Cisplatin—bone cancer	0.00848	0.00927	CcSEcCtD
Misoprostol—Polyuria—Cisplatin—bone cancer	0.00832	0.0091	CcSEcCtD
Misoprostol—Deafness—Cisplatin—bone cancer	0.00816	0.00893	CcSEcCtD
Misoprostol—Embolism—Epirubicin—bone cancer	0.00805	0.0088	CcSEcCtD
Misoprostol—Embolism—Doxorubicin—bone cancer	0.00745	0.00814	CcSEcCtD
Misoprostol—Gastrointestinal haemorrhage—Cisplatin—bone cancer	0.0073	0.00799	CcSEcCtD
Misoprostol—Gingivitis—Methotrexate—bone cancer	0.00703	0.00769	CcSEcCtD
Misoprostol—Vaginal haemorrhage—Epirubicin—bone cancer	0.00698	0.00763	CcSEcCtD
Misoprostol—Dehydration—Cisplatin—bone cancer	0.00679	0.00743	CcSEcCtD
Misoprostol—Breast disorder—Cisplatin—bone cancer	0.0066	0.00722	CcSEcCtD
Misoprostol—Gingivitis—Epirubicin—bone cancer	0.00658	0.0072	CcSEcCtD
Misoprostol—Cramp muscle—Cisplatin—bone cancer	0.00658	0.00719	CcSEcCtD
Misoprostol—Vaginal haemorrhage—Doxorubicin—bone cancer	0.00646	0.00706	CcSEcCtD
Misoprostol—Glycosuria—Epirubicin—bone cancer	0.00638	0.00697	CcSEcCtD
Misoprostol—Rigors—Epirubicin—bone cancer	0.00633	0.00692	CcSEcCtD
Misoprostol—Musculoskeletal stiffness—Methotrexate—bone cancer	0.00615	0.00673	CcSEcCtD
Misoprostol—Sweating increased—Cisplatin—bone cancer	0.00615	0.00672	CcSEcCtD
Misoprostol—Gingivitis—Doxorubicin—bone cancer	0.00609	0.00666	CcSEcCtD
Misoprostol—Breast pain—Epirubicin—bone cancer	0.00592	0.00648	CcSEcCtD
Misoprostol—Glycosuria—Doxorubicin—bone cancer	0.0059	0.00645	CcSEcCtD
Misoprostol—Rigors—Doxorubicin—bone cancer	0.00585	0.0064	CcSEcCtD
Misoprostol—Inflammation—Methotrexate—bone cancer	0.00569	0.00622	CcSEcCtD
Misoprostol—Acute coronary syndrome—Cisplatin—bone cancer	0.00555	0.00607	CcSEcCtD
Misoprostol—Pulmonary embolism—Methotrexate—bone cancer	0.00552	0.00604	CcSEcCtD
Misoprostol—Neuropathy peripheral—Cisplatin—bone cancer	0.00552	0.00603	CcSEcCtD
Misoprostol—Myocardial infarction—Cisplatin—bone cancer	0.00552	0.00603	CcSEcCtD
Misoprostol—Breast pain—Doxorubicin—bone cancer	0.00548	0.00599	CcSEcCtD
Misoprostol—Conjunctivitis—Cisplatin—bone cancer	0.00547	0.00598	CcSEcCtD
Misoprostol—PTGER2—Ovarian Infertility Genes—CDK4—bone cancer	0.00534	0.0623	CbGpPWpGaD
Misoprostol—Inflammation—Epirubicin—bone cancer	0.00533	0.00583	CcSEcCtD
Misoprostol—Phosphatase alkaline increased—Epirubicin—bone cancer	0.00517	0.00565	CcSEcCtD
Misoprostol—Pulmonary embolism—Epirubicin—bone cancer	0.00517	0.00565	CcSEcCtD
Misoprostol—Urine output increased—Methotrexate—bone cancer	0.00499	0.00546	CcSEcCtD
Misoprostol—Inflammation—Doxorubicin—bone cancer	0.00493	0.00539	CcSEcCtD
Misoprostol—PTGER4—Prostaglandin Synthesis and Regulation—PTGS2—bone cancer	0.00489	0.0571	CbGpPWpGaD
Misoprostol—Visual impairment—Cisplatin—bone cancer	0.00487	0.00532	CcSEcCtD
Misoprostol—Neuropathy—Epirubicin—bone cancer	0.00485	0.0053	CcSEcCtD
Misoprostol—Phosphatase alkaline increased—Doxorubicin—bone cancer	0.00478	0.00523	CcSEcCtD
Misoprostol—Pulmonary embolism—Doxorubicin—bone cancer	0.00478	0.00523	CcSEcCtD
Misoprostol—Tinnitus—Cisplatin—bone cancer	0.00471	0.00515	CcSEcCtD
Misoprostol—Polyuria—Methotrexate—bone cancer	0.00456	0.00499	CcSEcCtD
Misoprostol—Immune system disorder—Cisplatin—bone cancer	0.00456	0.00499	CcSEcCtD
Misoprostol—Arrhythmia—Cisplatin—bone cancer	0.00451	0.00494	CcSEcCtD
Misoprostol—Abnormal vision—Epirubicin—bone cancer	0.00451	0.00493	CcSEcCtD
Misoprostol—Neuropathy—Doxorubicin—bone cancer	0.00449	0.00491	CcSEcCtD
Misoprostol—Alopecia—Cisplatin—bone cancer	0.00446	0.00488	CcSEcCtD
Misoprostol—Phlebitis—Epirubicin—bone cancer	0.00435	0.00476	CcSEcCtD
Misoprostol—Flatulence—Cisplatin—bone cancer	0.00433	0.00474	CcSEcCtD
Misoprostol—Blood alkaline phosphatase increased—Epirubicin—bone cancer	0.00431	0.00472	CcSEcCtD
Misoprostol—Muscle spasms—Cisplatin—bone cancer	0.00423	0.00462	CcSEcCtD
Misoprostol—Vascular purpura—Epirubicin—bone cancer	0.00419	0.00458	CcSEcCtD
Misoprostol—Abnormal vision—Doxorubicin—bone cancer	0.00417	0.00456	CcSEcCtD
Misoprostol—Anaemia—Cisplatin—bone cancer	0.00406	0.00445	CcSEcCtD
Misoprostol—Phlebitis—Doxorubicin—bone cancer	0.00403	0.00441	CcSEcCtD
Misoprostol—PTGER2—Prostaglandin Synthesis and Regulation—PTGS2—bone cancer	0.00402	0.0469	CbGpPWpGaD
Misoprostol—Blood alkaline phosphatase increased—Doxorubicin—bone cancer	0.00399	0.00436	CcSEcCtD
Misoprostol—Purpura—Epirubicin—bone cancer	0.00389	0.00426	CcSEcCtD
Misoprostol—Vascular purpura—Doxorubicin—bone cancer	0.00388	0.00424	CcSEcCtD
Misoprostol—Gastrointestinal haemorrhage—Epirubicin—bone cancer	0.00375	0.0041	CcSEcCtD
Misoprostol—Myalgia—Cisplatin—bone cancer	0.00374	0.00409	CcSEcCtD
Misoprostol—Anxiety—Cisplatin—bone cancer	0.00373	0.00408	CcSEcCtD
Misoprostol—PTGER3—Prostaglandin Synthesis and Regulation—PTGS2—bone cancer	0.00371	0.0433	CbGpPWpGaD
Misoprostol—Breast disorder—Methotrexate—bone cancer	0.00362	0.00396	CcSEcCtD
Misoprostol—Purpura—Doxorubicin—bone cancer	0.0036	0.00394	CcSEcCtD
Misoprostol—Anaphylactic shock—Cisplatin—bone cancer	0.00359	0.00393	CcSEcCtD
Misoprostol—Oedema—Cisplatin—bone cancer	0.00359	0.00393	CcSEcCtD
Misoprostol—Infection—Cisplatin—bone cancer	0.00357	0.0039	CcSEcCtD
Misoprostol—Thrombocytopenia—Cisplatin—bone cancer	0.00351	0.00384	CcSEcCtD
Misoprostol—Dehydration—Epirubicin—bone cancer	0.00349	0.00381	CcSEcCtD
Misoprostol—Gastrointestinal haemorrhage—Doxorubicin—bone cancer	0.00347	0.0038	CcSEcCtD
Misoprostol—Hyperhidrosis—Cisplatin—bone cancer	0.00347	0.00379	CcSEcCtD
Misoprostol—Breast disorder—Epirubicin—bone cancer	0.00339	0.00371	CcSEcCtD
Misoprostol—Hypotension—Cisplatin—bone cancer	0.00335	0.00367	CcSEcCtD
Misoprostol—Musculoskeletal discomfort—Cisplatin—bone cancer	0.00327	0.00358	CcSEcCtD
Misoprostol—Dysphagia—Epirubicin—bone cancer	0.00324	0.00354	CcSEcCtD
Misoprostol—Dysuria—Methotrexate—bone cancer	0.00324	0.00354	CcSEcCtD
Misoprostol—Dehydration—Doxorubicin—bone cancer	0.00323	0.00353	CcSEcCtD
Misoprostol—Upper respiratory tract infection—Methotrexate—bone cancer	0.00322	0.00352	CcSEcCtD
Misoprostol—Dyspnoea—Cisplatin—bone cancer	0.0032	0.0035	CcSEcCtD
Misoprostol—Erectile dysfunction—Methotrexate—bone cancer	0.00319	0.00349	CcSEcCtD
Misoprostol—PTGER3—G alpha (i) signalling events—GRM4—bone cancer	0.00318	0.0371	CbGpPWpGaD
Misoprostol—PTGER3—G alpha (i) signalling events—RGS1—bone cancer	0.00318	0.0371	CbGpPWpGaD
Misoprostol—Breast disorder—Doxorubicin—bone cancer	0.00314	0.00343	CcSEcCtD
Misoprostol—Bronchitis—Epirubicin—bone cancer	0.00312	0.00341	CcSEcCtD
Misoprostol—Pneumonia—Methotrexate—bone cancer	0.00311	0.0034	CcSEcCtD
Misoprostol—Drowsiness—Methotrexate—bone cancer	0.00309	0.00338	CcSEcCtD
Misoprostol—Pain—Cisplatin—bone cancer	0.00307	0.00336	CcSEcCtD
Misoprostol—Dysuria—Epirubicin—bone cancer	0.00303	0.00331	CcSEcCtD
Misoprostol—Upper respiratory tract infection—Epirubicin—bone cancer	0.00301	0.00329	CcSEcCtD
Misoprostol—Conjunctivitis—Methotrexate—bone cancer	0.003	0.00328	CcSEcCtD
Misoprostol—Dysphagia—Doxorubicin—bone cancer	0.003	0.00328	CcSEcCtD
Misoprostol—Feeling abnormal—Cisplatin—bone cancer	0.00296	0.00323	CcSEcCtD
Misoprostol—Haematuria—Methotrexate—bone cancer	0.00294	0.00322	CcSEcCtD
Misoprostol—Epistaxis—Methotrexate—bone cancer	0.00291	0.00319	CcSEcCtD
Misoprostol—Pneumonia—Epirubicin—bone cancer	0.00291	0.00318	CcSEcCtD
Misoprostol—Drowsiness—Epirubicin—bone cancer	0.00289	0.00316	CcSEcCtD
Misoprostol—Bronchitis—Doxorubicin—bone cancer	0.00288	0.00315	CcSEcCtD
Misoprostol—Body temperature increased—Cisplatin—bone cancer	0.00284	0.0031	CcSEcCtD
Misoprostol—Neuropathy peripheral—Epirubicin—bone cancer	0.00283	0.0031	CcSEcCtD
Misoprostol—Urinary tract infection—Epirubicin—bone cancer	0.00281	0.00307	CcSEcCtD
Misoprostol—Conjunctivitis—Epirubicin—bone cancer	0.00281	0.00307	CcSEcCtD
Misoprostol—Dysuria—Doxorubicin—bone cancer	0.0028	0.00307	CcSEcCtD
Misoprostol—Upper respiratory tract infection—Doxorubicin—bone cancer	0.00279	0.00305	CcSEcCtD
Misoprostol—Haematuria—Epirubicin—bone cancer	0.00276	0.00301	CcSEcCtD
Misoprostol—Epistaxis—Epirubicin—bone cancer	0.00273	0.00298	CcSEcCtD
Misoprostol—Pneumonia—Doxorubicin—bone cancer	0.00269	0.00294	CcSEcCtD
Misoprostol—Drowsiness—Doxorubicin—bone cancer	0.00267	0.00292	CcSEcCtD
Misoprostol—Visual impairment—Methotrexate—bone cancer	0.00267	0.00292	CcSEcCtD
Misoprostol—Hypersensitivity—Cisplatin—bone cancer	0.00264	0.00289	CcSEcCtD
Misoprostol—Neuropathy peripheral—Doxorubicin—bone cancer	0.00262	0.00287	CcSEcCtD
Misoprostol—Urinary tract infection—Doxorubicin—bone cancer	0.0026	0.00284	CcSEcCtD
Misoprostol—Conjunctivitis—Doxorubicin—bone cancer	0.0026	0.00284	CcSEcCtD
Misoprostol—Tinnitus—Methotrexate—bone cancer	0.00258	0.00283	CcSEcCtD
Misoprostol—Asthenia—Cisplatin—bone cancer	0.00257	0.00282	CcSEcCtD
Misoprostol—Haematuria—Doxorubicin—bone cancer	0.00255	0.00279	CcSEcCtD
Misoprostol—PTGER4—GPCR ligand binding—GRM4—bone cancer	0.00254	0.0297	CbGpPWpGaD
Misoprostol—Epistaxis—Doxorubicin—bone cancer	0.00252	0.00276	CcSEcCtD
Misoprostol—Immune system disorder—Methotrexate—bone cancer	0.0025	0.00274	CcSEcCtD
Misoprostol—Visual impairment—Epirubicin—bone cancer	0.0025	0.00273	CcSEcCtD
Misoprostol—Chills—Methotrexate—bone cancer	0.00249	0.00272	CcSEcCtD
Misoprostol—Diarrhoea—Cisplatin—bone cancer	0.00246	0.00269	CcSEcCtD
Misoprostol—Alopecia—Methotrexate—bone cancer	0.00245	0.00268	CcSEcCtD
Misoprostol—Tinnitus—Epirubicin—bone cancer	0.00242	0.00265	CcSEcCtD
Misoprostol—Immune system disorder—Epirubicin—bone cancer	0.00234	0.00256	CcSEcCtD
Misoprostol—Back pain—Methotrexate—bone cancer	0.00233	0.00255	CcSEcCtD
Misoprostol—Chills—Epirubicin—bone cancer	0.00233	0.00255	CcSEcCtD
Misoprostol—Arrhythmia—Epirubicin—bone cancer	0.00232	0.00253	CcSEcCtD
Misoprostol—Visual impairment—Doxorubicin—bone cancer	0.00231	0.00253	CcSEcCtD
Misoprostol—Alopecia—Epirubicin—bone cancer	0.00229	0.00251	CcSEcCtD
Misoprostol—Vomiting—Cisplatin—bone cancer	0.00228	0.0025	CcSEcCtD
Misoprostol—Rash—Cisplatin—bone cancer	0.00226	0.00248	CcSEcCtD
Misoprostol—Dermatitis—Cisplatin—bone cancer	0.00226	0.00247	CcSEcCtD
Misoprostol—Tinnitus—Doxorubicin—bone cancer	0.00224	0.00245	CcSEcCtD
Misoprostol—Anaemia—Methotrexate—bone cancer	0.00223	0.00244	CcSEcCtD
Misoprostol—Flatulence—Epirubicin—bone cancer	0.00223	0.00243	CcSEcCtD
Misoprostol—PTGER4—GPCR ligand binding—GRM1—bone cancer	0.00221	0.0257	CbGpPWpGaD
Misoprostol—Back pain—Epirubicin—bone cancer	0.00218	0.00239	CcSEcCtD
Misoprostol—Muscle spasms—Epirubicin—bone cancer	0.00217	0.00237	CcSEcCtD
Misoprostol—Immune system disorder—Doxorubicin—bone cancer	0.00217	0.00237	CcSEcCtD
Misoprostol—Chills—Doxorubicin—bone cancer	0.00215	0.00236	CcSEcCtD
Misoprostol—Arrhythmia—Doxorubicin—bone cancer	0.00214	0.00235	CcSEcCtD
Misoprostol—Nausea—Cisplatin—bone cancer	0.00213	0.00233	CcSEcCtD
Misoprostol—Alopecia—Doxorubicin—bone cancer	0.00212	0.00232	CcSEcCtD
Misoprostol—PTGER2—GPCR ligand binding—GRM4—bone cancer	0.00209	0.0244	CbGpPWpGaD
Misoprostol—Anaemia—Epirubicin—bone cancer	0.00209	0.00228	CcSEcCtD
Misoprostol—Flatulence—Doxorubicin—bone cancer	0.00206	0.00225	CcSEcCtD
Misoprostol—Chest pain—Methotrexate—bone cancer	0.00205	0.00225	CcSEcCtD
Misoprostol—Arthralgia—Methotrexate—bone cancer	0.00205	0.00225	CcSEcCtD
Misoprostol—Myalgia—Methotrexate—bone cancer	0.00205	0.00225	CcSEcCtD
Misoprostol—Syncope—Epirubicin—bone cancer	0.00203	0.00222	CcSEcCtD
Misoprostol—Back pain—Doxorubicin—bone cancer	0.00202	0.00221	CcSEcCtD
Misoprostol—Muscle spasms—Doxorubicin—bone cancer	0.00201	0.0022	CcSEcCtD
Misoprostol—Confusional state—Methotrexate—bone cancer	0.00199	0.00217	CcSEcCtD
Misoprostol—Loss of consciousness—Epirubicin—bone cancer	0.00198	0.00217	CcSEcCtD
Misoprostol—Anaphylactic shock—Methotrexate—bone cancer	0.00197	0.00215	CcSEcCtD
Misoprostol—Infection—Methotrexate—bone cancer	0.00196	0.00214	CcSEcCtD
Misoprostol—Hypertension—Epirubicin—bone cancer	0.00195	0.00213	CcSEcCtD
Misoprostol—Anaemia—Doxorubicin—bone cancer	0.00193	0.00211	CcSEcCtD
Misoprostol—Thrombocytopenia—Methotrexate—bone cancer	0.00193	0.00211	CcSEcCtD
Misoprostol—PTGER3—GPCR ligand binding—GRM4—bone cancer	0.00193	0.0225	CbGpPWpGaD
Misoprostol—Chest pain—Epirubicin—bone cancer	0.00192	0.0021	CcSEcCtD
Misoprostol—Myalgia—Epirubicin—bone cancer	0.00192	0.0021	CcSEcCtD
Misoprostol—Arthralgia—Epirubicin—bone cancer	0.00192	0.0021	CcSEcCtD
Misoprostol—Anxiety—Epirubicin—bone cancer	0.00192	0.0021	CcSEcCtD
Misoprostol—Hyperhidrosis—Methotrexate—bone cancer	0.0019	0.00208	CcSEcCtD
Misoprostol—Syncope—Doxorubicin—bone cancer	0.00187	0.00205	CcSEcCtD
Misoprostol—Confusional state—Epirubicin—bone cancer	0.00186	0.00203	CcSEcCtD
Misoprostol—Anaphylactic shock—Epirubicin—bone cancer	0.00184	0.00202	CcSEcCtD
Misoprostol—Oedema—Epirubicin—bone cancer	0.00184	0.00202	CcSEcCtD
Misoprostol—Hypotension—Methotrexate—bone cancer	0.00184	0.00201	CcSEcCtD
Misoprostol—Loss of consciousness—Doxorubicin—bone cancer	0.00184	0.00201	CcSEcCtD
Misoprostol—Infection—Epirubicin—bone cancer	0.00183	0.002	CcSEcCtD
Misoprostol—Shock—Epirubicin—bone cancer	0.00181	0.00198	CcSEcCtD
Misoprostol—PTGER2—GPCR ligand binding—GRM1—bone cancer	0.00181	0.0211	CbGpPWpGaD
Misoprostol—Thrombocytopenia—Epirubicin—bone cancer	0.0018	0.00197	CcSEcCtD
Misoprostol—Hypertension—Doxorubicin—bone cancer	0.0018	0.00197	CcSEcCtD
Misoprostol—Musculoskeletal discomfort—Methotrexate—bone cancer	0.00179	0.00196	CcSEcCtD
Misoprostol—Hyperhidrosis—Epirubicin—bone cancer	0.00178	0.00195	CcSEcCtD
Misoprostol—Arthralgia—Doxorubicin—bone cancer	0.00178	0.00195	CcSEcCtD
Misoprostol—Chest pain—Doxorubicin—bone cancer	0.00178	0.00195	CcSEcCtD
Misoprostol—Myalgia—Doxorubicin—bone cancer	0.00178	0.00195	CcSEcCtD
Misoprostol—Anxiety—Doxorubicin—bone cancer	0.00177	0.00194	CcSEcCtD
Misoprostol—Dyspnoea—Methotrexate—bone cancer	0.00176	0.00192	CcSEcCtD
Misoprostol—Somnolence—Methotrexate—bone cancer	0.00175	0.00191	CcSEcCtD
Misoprostol—Dyspepsia—Methotrexate—bone cancer	0.00173	0.0019	CcSEcCtD
Misoprostol—Hypotension—Epirubicin—bone cancer	0.00172	0.00188	CcSEcCtD
Misoprostol—Confusional state—Doxorubicin—bone cancer	0.00172	0.00188	CcSEcCtD
Misoprostol—Anaphylactic shock—Doxorubicin—bone cancer	0.00171	0.00187	CcSEcCtD
Misoprostol—Oedema—Doxorubicin—bone cancer	0.00171	0.00187	CcSEcCtD
Misoprostol—Fatigue—Methotrexate—bone cancer	0.0017	0.00186	CcSEcCtD
Misoprostol—Infection—Doxorubicin—bone cancer	0.00169	0.00185	CcSEcCtD
Misoprostol—Pain—Methotrexate—bone cancer	0.00168	0.00184	CcSEcCtD
Misoprostol—Musculoskeletal discomfort—Epirubicin—bone cancer	0.00168	0.00184	CcSEcCtD
Misoprostol—Shock—Doxorubicin—bone cancer	0.00168	0.00184	CcSEcCtD
Misoprostol—PTGER3—GPCR ligand binding—GRM1—bone cancer	0.00167	0.0195	CbGpPWpGaD
Misoprostol—Thrombocytopenia—Doxorubicin—bone cancer	0.00167	0.00183	CcSEcCtD
Misoprostol—Hyperhidrosis—Doxorubicin—bone cancer	0.00165	0.0018	CcSEcCtD
Misoprostol—Dyspnoea—Epirubicin—bone cancer	0.00164	0.0018	CcSEcCtD
Misoprostol—Somnolence—Epirubicin—bone cancer	0.00164	0.00179	CcSEcCtD
Misoprostol—Feeling abnormal—Methotrexate—bone cancer	0.00162	0.00178	CcSEcCtD
Misoprostol—Dyspepsia—Epirubicin—bone cancer	0.00162	0.00177	CcSEcCtD
Misoprostol—Gastrointestinal pain—Methotrexate—bone cancer	0.00161	0.00176	CcSEcCtD
Misoprostol—Hypotension—Doxorubicin—bone cancer	0.00159	0.00174	CcSEcCtD
Misoprostol—Fatigue—Epirubicin—bone cancer	0.00159	0.00174	CcSEcCtD
Misoprostol—Pain—Epirubicin—bone cancer	0.00158	0.00172	CcSEcCtD
Misoprostol—Constipation—Epirubicin—bone cancer	0.00158	0.00172	CcSEcCtD
Misoprostol—Body temperature increased—Methotrexate—bone cancer	0.00156	0.0017	CcSEcCtD
Misoprostol—Abdominal pain—Methotrexate—bone cancer	0.00156	0.0017	CcSEcCtD
Misoprostol—PTGER4—GPCR ligand binding—SMO—bone cancer	0.00155	0.0181	CbGpPWpGaD
Misoprostol—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.00155	0.0017	CcSEcCtD
Misoprostol—Dyspnoea—Doxorubicin—bone cancer	0.00152	0.00166	CcSEcCtD
Misoprostol—Feeling abnormal—Epirubicin—bone cancer	0.00152	0.00166	CcSEcCtD
Misoprostol—Somnolence—Doxorubicin—bone cancer	0.00152	0.00166	CcSEcCtD
Misoprostol—Gastrointestinal pain—Epirubicin—bone cancer	0.00151	0.00165	CcSEcCtD
Misoprostol—Dyspepsia—Doxorubicin—bone cancer	0.0015	0.00164	CcSEcCtD
Misoprostol—Fatigue—Doxorubicin—bone cancer	0.00147	0.00161	CcSEcCtD
Misoprostol—Pain—Doxorubicin—bone cancer	0.00146	0.0016	CcSEcCtD
Misoprostol—Constipation—Doxorubicin—bone cancer	0.00146	0.0016	CcSEcCtD
Misoprostol—Abdominal pain—Epirubicin—bone cancer	0.00146	0.00159	CcSEcCtD
Misoprostol—Body temperature increased—Epirubicin—bone cancer	0.00146	0.00159	CcSEcCtD
Misoprostol—Hypersensitivity—Methotrexate—bone cancer	0.00145	0.00159	CcSEcCtD
Misoprostol—PTGER4—GPCR downstream signaling—RGS1—bone cancer	0.00144	0.0168	CbGpPWpGaD
Misoprostol—PTGER4—GPCR downstream signaling—GRM4—bone cancer	0.00144	0.0168	CbGpPWpGaD
Misoprostol—Asthenia—Methotrexate—bone cancer	0.00141	0.00155	CcSEcCtD
Misoprostol—Feeling abnormal—Doxorubicin—bone cancer	0.00141	0.00154	CcSEcCtD
Misoprostol—Gastrointestinal pain—Doxorubicin—bone cancer	0.00139	0.00153	CcSEcCtD
Misoprostol—Hypersensitivity—Epirubicin—bone cancer	0.00136	0.00149	CcSEcCtD
Misoprostol—Abdominal pain—Doxorubicin—bone cancer	0.00135	0.00147	CcSEcCtD
Misoprostol—Body temperature increased—Doxorubicin—bone cancer	0.00135	0.00147	CcSEcCtD
Misoprostol—Diarrhoea—Methotrexate—bone cancer	0.00135	0.00147	CcSEcCtD
Misoprostol—Asthenia—Epirubicin—bone cancer	0.00132	0.00145	CcSEcCtD
Misoprostol—PTGER4—Signaling by GPCR—RGS1—bone cancer	0.00131	0.0152	CbGpPWpGaD
Misoprostol—PTGER4—Signaling by GPCR—GRM4—bone cancer	0.00131	0.0152	CbGpPWpGaD
Misoprostol—Dizziness—Methotrexate—bone cancer	0.0013	0.00142	CcSEcCtD
Misoprostol—PTGER2—GPCR ligand binding—SMO—bone cancer	0.00128	0.0149	CbGpPWpGaD
Misoprostol—Diarrhoea—Epirubicin—bone cancer	0.00126	0.00138	CcSEcCtD
Misoprostol—Hypersensitivity—Doxorubicin—bone cancer	0.00126	0.00137	CcSEcCtD
Misoprostol—Vomiting—Methotrexate—bone cancer	0.00125	0.00137	CcSEcCtD
Misoprostol—PTGER4—GPCR downstream signaling—GRM1—bone cancer	0.00125	0.0145	CbGpPWpGaD
Misoprostol—Rash—Methotrexate—bone cancer	0.00124	0.00136	CcSEcCtD
Misoprostol—Dermatitis—Methotrexate—bone cancer	0.00124	0.00136	CcSEcCtD
Misoprostol—Headache—Methotrexate—bone cancer	0.00123	0.00135	CcSEcCtD
Misoprostol—Asthenia—Doxorubicin—bone cancer	0.00122	0.00134	CcSEcCtD
Misoprostol—Dizziness—Epirubicin—bone cancer	0.00122	0.00133	CcSEcCtD
Misoprostol—PTGER2—GPCR downstream signaling—RGS1—bone cancer	0.00118	0.0138	CbGpPWpGaD
Misoprostol—PTGER2—GPCR downstream signaling—GRM4—bone cancer	0.00118	0.0138	CbGpPWpGaD
Misoprostol—PTGER3—GPCR ligand binding—SMO—bone cancer	0.00118	0.0137	CbGpPWpGaD
Misoprostol—Vomiting—Epirubicin—bone cancer	0.00117	0.00128	CcSEcCtD
Misoprostol—Nausea—Methotrexate—bone cancer	0.00117	0.00128	CcSEcCtD
Misoprostol—Diarrhoea—Doxorubicin—bone cancer	0.00117	0.00128	CcSEcCtD
Misoprostol—Rash—Epirubicin—bone cancer	0.00116	0.00127	CcSEcCtD
Misoprostol—Dermatitis—Epirubicin—bone cancer	0.00116	0.00127	CcSEcCtD
Misoprostol—Headache—Epirubicin—bone cancer	0.00115	0.00126	CcSEcCtD
Misoprostol—PTGER4—Signaling by GPCR—GRM1—bone cancer	0.00113	0.0132	CbGpPWpGaD
Misoprostol—Dizziness—Doxorubicin—bone cancer	0.00113	0.00123	CcSEcCtD
Misoprostol—Nausea—Epirubicin—bone cancer	0.00109	0.0012	CcSEcCtD
Misoprostol—PTGER3—GPCR downstream signaling—RGS1—bone cancer	0.00109	0.0127	CbGpPWpGaD
Misoprostol—PTGER3—GPCR downstream signaling—GRM4—bone cancer	0.00109	0.0127	CbGpPWpGaD
Misoprostol—Vomiting—Doxorubicin—bone cancer	0.00108	0.00119	CcSEcCtD
Misoprostol—Rash—Doxorubicin—bone cancer	0.00108	0.00118	CcSEcCtD
Misoprostol—Dermatitis—Doxorubicin—bone cancer	0.00107	0.00117	CcSEcCtD
Misoprostol—PTGER2—Signaling by GPCR—RGS1—bone cancer	0.00107	0.0125	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—GRM4—bone cancer	0.00107	0.0125	CbGpPWpGaD
Misoprostol—Headache—Doxorubicin—bone cancer	0.00107	0.00117	CcSEcCtD
Misoprostol—PTGER2—GPCR downstream signaling—GRM1—bone cancer	0.00102	0.0119	CbGpPWpGaD
Misoprostol—Nausea—Doxorubicin—bone cancer	0.00101	0.00111	CcSEcCtD
Misoprostol—PTGER3—Signaling by GPCR—RGS1—bone cancer	0.00099	0.0115	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—GRM4—bone cancer	0.00099	0.0115	CbGpPWpGaD
Misoprostol—PTGER3—GPCR downstream signaling—GRM1—bone cancer	0.000945	0.011	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—GRM1—bone cancer	0.00093	0.0108	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—GRM1—bone cancer	0.000858	0.01	CbGpPWpGaD
Misoprostol—PTGER4—GPCR downstream signaling—GNA11—bone cancer	0.000803	0.00937	CbGpPWpGaD
Misoprostol—PTGER4—Signaling by GPCR—SMO—bone cancer	0.000798	0.0093	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—GRM4—bone cancer	0.000771	0.009	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—RGS1—bone cancer	0.000771	0.009	CbGpPWpGaD
Misoprostol—PTGER4—Signaling by GPCR—GNA11—bone cancer	0.00073	0.00851	CbGpPWpGaD
Misoprostol—PTGER4—GPCR downstream signaling—IL3—bone cancer	0.000728	0.0085	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—GRM1—bone cancer	0.000669	0.0078	CbGpPWpGaD
Misoprostol—PTGER4—Signaling by GPCR—IL3—bone cancer	0.000661	0.00771	CbGpPWpGaD
Misoprostol—PTGER2—GPCR downstream signaling—GNA11—bone cancer	0.00066	0.0077	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—SMO—bone cancer	0.000655	0.00764	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—RGS1—bone cancer	0.000633	0.00739	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—GRM4—bone cancer	0.000633	0.00739	CbGpPWpGaD
Misoprostol—PTGER3—GPCR downstream signaling—GNA11—bone cancer	0.000609	0.0071	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—SMO—bone cancer	0.000605	0.00705	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—GNA11—bone cancer	0.000599	0.00699	CbGpPWpGaD
Misoprostol—PTGER2—GPCR downstream signaling—IL3—bone cancer	0.000598	0.00698	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—GRM4—bone cancer	0.000585	0.00682	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—RGS1—bone cancer	0.000585	0.00682	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—GNA11—bone cancer	0.000553	0.00645	CbGpPWpGaD
Misoprostol—PTGER3—GPCR downstream signaling—IL3—bone cancer	0.000552	0.00644	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—GRM1—bone cancer	0.000549	0.00641	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—IL3—bone cancer	0.000543	0.00634	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—GRM1—bone cancer	0.000507	0.00591	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—IL3—bone cancer	0.000501	0.00585	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—SMO—bone cancer	0.000471	0.0055	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—GNA11—bone cancer	0.000431	0.00503	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—ATF1—bone cancer	0.000401	0.00467	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—IL3—bone cancer	0.000391	0.00456	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—SMO—bone cancer	0.000387	0.00451	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—SMO—bone cancer	0.000357	0.00417	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—GNA11—bone cancer	0.000354	0.00413	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—TGFBR2—bone cancer	0.000334	0.0039	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—ATF1—bone cancer	0.000329	0.00384	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—GNA11—bone cancer	0.000327	0.00381	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—IL3—bone cancer	0.000321	0.00374	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—IGF1R—bone cancer	0.000314	0.00367	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—ATF1—bone cancer	0.000304	0.00354	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—IL3—bone cancer	0.000296	0.00345	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—TGFBR2—bone cancer	0.000274	0.0032	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—IGF1R—bone cancer	0.000258	0.00301	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—TGFBR2—bone cancer	0.000253	0.00295	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—IGF1R—bone cancer	0.000238	0.00278	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—KIT—bone cancer	0.000228	0.00266	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—BRAF—bone cancer	0.000214	0.0025	CbGpPWpGaD
Misoprostol—PTGER4—Signaling by GPCR—EGFR—bone cancer	0.000208	0.00242	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—KIT—bone cancer	0.000187	0.00218	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—MDM2—bone cancer	0.00018	0.00209	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—BRAF—bone cancer	0.000176	0.00205	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—KIT—bone cancer	0.000173	0.00202	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—EGFR—bone cancer	0.000171	0.00199	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—BRAF—bone cancer	0.000162	0.00189	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—EGFR—bone cancer	0.000157	0.00184	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—JUN—bone cancer	0.000156	0.00182	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—MMP9—bone cancer	0.000152	0.00177	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—MDM2—bone cancer	0.000147	0.00172	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—MDM2—bone cancer	0.000136	0.00159	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—JUN—bone cancer	0.000128	0.0015	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—MMP9—bone cancer	0.000125	0.00145	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—EGFR—bone cancer	0.000123	0.00143	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—JUN—bone cancer	0.000118	0.00138	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—MMP9—bone cancer	0.000115	0.00134	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—TP53—bone cancer	0.000103	0.0012	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—EGFR—bone cancer	0.000101	0.00118	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—EGFR—bone cancer	9.3e-05	0.00108	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—TP53—bone cancer	8.46e-05	0.000987	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—TP53—bone cancer	7.81e-05	0.000911	CbGpPWpGaD
